This announcement is a separate document:
久光製薬：AMEDによるワクチン・新規モダリティ研究開発事業（一般公募）の公募採択のお知らせ
Hisamitsu Pharmaceutical: Notice of adoption of an open call for the vaccine/novel modality research and development project (public call) by AMED
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated